Skip to main content

Advertisement

Log in

The serine protease inhibitor of Kazal-type 7 (SPINK7) is expressed in human skin

  • Concise Communication
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Proteases and their inhibitors play an important role in epidermal homeostasis. Their imbalance contributes to severe skin diseases. SPINK7 is a member of the SPINK protease inhibitor family and has been described so far as a cancer-related gene in the esophagus. Herein, we describe for the first time its expression in healthy human skin. Moreover, SPINK7 is up-regulated in inflammatory skin diseases like psoriasis and eczema as demonstrated by immunohistochemistry, though real-time PCR analyses revealed no significant up-regulation. In cultured keratinocytes, SPINK7 mRNA expression was up-regulated by IL-17A together with IFNγ. Our observation points to a role of SPINK7 in skin homeostasis and its involvement in inflammatory skin diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Abbreviations

GAPDH:

Glyceraldehyde dehydrogenase

KLK:

Kallikrein-related peptidase

NHEC:

Natural human epidermal keratinocytes

SPINK:

Serine protease inhibitor of Kazal-type

LEKTI:

Lympho-epithelial Kazal-type inhibitor

References

  1. Borgono CA, Michael IP, Komatsu N, Jayakumar A, Kapadia R, Clayman GL, Sotiropoulou G, Diamandis EP (2007) A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 282:3640–3652

    Article  CAS  PubMed  Google Scholar 

  2. Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafe JL, Wilkinson J, Taieb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141–142

    Article  CAS  PubMed  Google Scholar 

  3. Cheng X, Shen Z, Yin L, Lu SH, Cui Y (2009) ECRG2 regulates cell migration/invasion through urokinase-type plasmin activator receptor (uPAR)/beta1 integrin pathway. J Biol Chem 284:30897–30906. doi:10.1074/jbc.M109.011213

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Cui Y, Bi M, Su T, Liu H, Lu SH (2010) Molecular cloning and characterization of a novel esophageal cancer related gene. Int J Oncol 37:1521–1528

    CAS  PubMed  Google Scholar 

  5. Dubertret L, Bertaux B, Fosse M, Touraine R (1982) Localization of proteolytic activity in psoriatic skin. Br J Dermatol 107:499–504

    Article  CAS  PubMed  Google Scholar 

  6. Kantyka T, Fischer J, Wu Z, Declercq W, Reiss K, Schroder JM, Meyer-Hoffert U (2011) Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6. Peptides 32:1187–1192

    Article  CAS  PubMed  Google Scholar 

  7. Meyer-Hoffert U (2009) Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases. Arch Immunol Ther Exp (Warsz) 57:345–354

    Article  CAS  Google Scholar 

  8. Meyer-Hoffert U, Wu Z, Kantyka T, Fischer J, Latendorf T, Hansmann B, Bartels J, He Y, Glaser R, Schroder JM (2010) Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases. J Biol Chem 285:32174–32181

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Meyer-Hoffert U, Wu Z, Schroder JM (2009) Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor. PLoS One 4:e4372

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ong C, O’Toole EA, Ghali L, Malone M, Smith VV, Callard R, Harper JI (2004) LEKTI demonstrable by immunohistochemistry of the skin: a potential diagnostic skin test for Netherton syndrome. Br J Dermatol 151:1253–1257. doi:10.1111/j.1365-2133.2004.06180.x

    Article  CAS  PubMed  Google Scholar 

  11. Proksch E, Brasch J (2012) Abnormal epidermal barrier in the pathogenesis of contact dermatitis. Clin Dermatol 30:335–344. doi:10.1016/j.clindermatol.2011.08.019

    Article  PubMed  Google Scholar 

  12. Redelfs L, Fischer J, Weber C, Wu Z, Meyer-Hoffert U (2016) The serine protease inhibitor of Kazal-type 9 (SPINK9) is expressed in lichen simplex chronicus, actinic keratosis and squamous cell carcinoma. Arch Dermatol Res 308:133–137. doi:10.1007/s00403-015-1616-5

    Article  CAS  PubMed  Google Scholar 

  13. Schon MP (2014) The plot thickens while the scope broadens: a holistic view on IL-17 in psoriasis and other inflammatory disorders. Exp Dermatol 23:804–806. doi:10.1111/exd.12541

    Article  PubMed  Google Scholar 

  14. Simanski M, Rademacher F, Schroder L, Schumacher HM, Glaser R, Harder J (2013) IL-17A and IFN-gamma synergistically induce RNase 7 expression via STAT3 in primary keratinocytes. PLoS One 8:e59531. doi:10.1371/journal.pone.0059531

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Voegeli R, Rawlings AV, Breternitz M, Doppler S, Schreier T, Fluhr JW (2009) Increased stratum corneum serine protease activity in acute eczematous atopic skin. Br J Dermatol 161:70–77

    Article  CAS  PubMed  Google Scholar 

  16. Ye L, Lv C, Man G, Song S, Elias PM, Man MQ (2014) Abnormal epidermal barrier recovery in uninvolved skin supports the notion of an epidermal pathogenesis of psoriasis. J Investig Dermatol 134:2843–2846. doi:10.1038/jid.2014.205

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was part of the medical doctor thesis of Clemens Weber.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ulf Meyer-Hoffert.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

Deutsche Forschungsgemeinschaft Me2037/3-3 (UMH) and the National Natural Science Foundation of China No.81472866 (ZW).

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Biopsies of patients were taken due to obtain dermatological diagnoses at the Department of Dermatology, University Kiel. Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weber, C., Fischer, J., Redelfs, L. et al. The serine protease inhibitor of Kazal-type 7 (SPINK7) is expressed in human skin. Arch Dermatol Res 309, 767–771 (2017). https://doi.org/10.1007/s00403-017-1773-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-017-1773-9

Keywords

Navigation